BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality.
BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality.
Authors: G Lefèvre; S Looareesuwan; S Treeprasertsuk; S Krudsood; U Silachamroon; I Gathmann; R Mull; R Bakshi Journal: Am J Trop Med Hyg Date: 2001 May-Jun Impact factor: 2.345
Authors: J A Kurtzhals; M M Addae; B D Akanmori; S Dunyo; K A Koram; M A Appawu; F K Nkrumah; L Hviid Journal: Trans R Soc Trop Med Hyg Date: 1999 Nov-Dec Impact factor: 2.184
Authors: Frederick N Baliraine; Yaw A Afrane; Dolphine A Amenya; Mariangela Bonizzoni; David M Menge; Goufa Zhou; Daibin Zhong; Anne M Vardo-Zalik; Andrew K Githeko; Guiyun Yan Journal: J Infect Dis Date: 2009-07-01 Impact factor: 5.226
Authors: Lorenz von Seidlein; Gijs Walraven; Paul J Milligan; Neal Alexander; Fandingding Manneh; Jacqueline L Deen; Roz Coleman; Musa Jawara; Steve W Lindsay; Chris Drakeley; Sarah De Martin; Piero Olliaro; Steve Bennett; Maarten Schim van der Loeff; Kunle Okunoye; Geoff A Targett; Keith P McAdam; Justin F Doherty; Brian M Greenwood; Margaret Pinder Journal: Trans R Soc Trop Med Hyg Date: 2003 Mar-Apr Impact factor: 2.184
Authors: Colin J Sutherland; Rosalynn Ord; Sam Dunyo; Musa Jawara; Christopher J Drakeley; Neal Alexander; Rosalind Coleman; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett Journal: PLoS Med Date: 2005-04-26 Impact factor: 11.069
Authors: Achuyt Bhattarai; Abdullah S Ali; S Patrick Kachur; Andreas Mårtensson; Ali K Abbas; Rashid Khatib; Abdul-Wahiyd Al-Mafazy; Mahdi Ramsan; Guida Rotllant; Jan F Gerstenmaier; Fabrizio Molteni; Salim Abdulla; Scott M Montgomery; Akira Kaneko; Anders Björkman Journal: PLoS Med Date: 2007-11-06 Impact factor: 11.069
Authors: Kathryn E Tiedje; Abraham R Oduro; Godfred Agongo; Thomas Anyorigiya; Daniel Azongo; Timothy Awine; Anita Ghansah; Mercedes Pascual; Kwadwo A Koram; Karen P Day Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Silvia Portugal; Tuan M Tran; Aissata Ongoiba; Aboudramane Bathily; Shanping Li; Safiatou Doumbo; Jeff Skinner; Didier Doumtabe; Younoussou Kone; Jules Sangala; Aarti Jain; D Huw Davies; Christopher Hung; Li Liang; Stacy Ricklefs; Manijeh Vafa Homann; Philip L Felgner; Stephen F Porcella; Anna Färnert; Ogobara K Doumbo; Kassoum Kayentao; Brian M Greenwood; Boubacar Traore; Peter D Crompton Journal: Clin Infect Dis Date: 2017-03-01 Impact factor: 9.079
Authors: Julia C Pringle; Sofonias Tessema; Amy Wesolowski; Anna Chen; Maxwell Murphy; Giovanna Carpi; Timothy M Shields; Harry Hamapumbu; Kelly M Searle; Tamaki Kobayashi; Ben Katowa; Michael Musonda; Jennifer C Stevenson; Philip E Thuma; Bryan Greenhouse; William J Moss; Douglas E Norris Journal: J Infect Dis Date: 2019-04-08 Impact factor: 5.226
Authors: Jeremy N Burrows; Rob Hooft van Huijsduijnen; Jörg J Möhrle; Claude Oeuvray; Timothy N C Wells Journal: Malar J Date: 2013-06-06 Impact factor: 2.979
Authors: Valerie Crowell; Olivier J T Briët; Diggory Hardy; Nakul Chitnis; Nicolas Maire; Aurelio Di Pasquale; Thomas A Smith Journal: Malar J Date: 2013-01-03 Impact factor: 2.979